Literature DB >> 25207196

Bleomycin-induced flagellate erythema.

Chun-Ching Lu1, Ying-Yi Lu2, Qing-Rui Wang3, Chieh-Hsin Wu4.   

Abstract

Entities:  

Year:  2014        PMID： 25207196      PMCID： PMC4115927          DOI： 10.5152/balkanmedj.2014.13277

Source DB:  PubMed          Journal:  Balkan Med J        ISSN： 2146-3123            Impact factor:   2.021


× No keyword cloud information.
  5 in total

Review 1.  Flagellate erythema.

Authors:  Toshiyuki Yamamoto; Kiyoshi Nishioka
Journal:  Int J Dermatol       Date:  2006-05       Impact factor: 2.736

2.  Flagellate erythema due to bleomycin.

Authors:  D Todkill; S Taibjee; A Borg; B C Gee
Journal:  Br J Haematol       Date:  2008-06-28       Impact factor: 6.998

3.  A pruritic rash in a patient with Hodgkin lymphoma. Bleomycin-induced flagellate dermatosis.

Authors:  R C Simpson; P Da Forno; C Nagarajan; K E Harman
Journal:  Clin Exp Dermatol       Date:  2011-08       Impact factor: 3.470

4.  Flagellate erythema secondary to bleomycin.

Authors:  W Khaliq; E S Antonarakis
Journal:  QJM       Date:  2011-08-24

5.  Shiitake dermatitis: the first case reported in Brazil.

Authors:  André Ricardo Adriano; Martha Liliana Acosta; David Rubem Azulay; Carlos Daniel Quiroz; Samantha Rodrigues Talarico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896
  5 in total
  3 in total

1.  Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2015-10-27

2.  Flagellate Rash: An Unusual Complication of Bleomycin Therapy - A Case Report with Brief Review of Literature.

Authors:  Chaturbhuj Agrawal; Vineet Talwar; Rajeev Saini; Pradeep Babu
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec

3.  Unusual and Interesting Adverse Cutaneous Drug Reactions.

Authors:  Vaishali Masatkar; Ashok Nagure; Lalit Kumar Gupta
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.